Journal ArticleOPEN ACCESS

NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826

  • Herrera A
  • LeBlanc M
  • Castellino S
  • et al.
Hematological Oncology (2023) 41(S2) 33-35
DOI: 10.1002/hon.3163_5
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Herrera, A. F., LeBlanc, M., Castellino, S. M., Li, H., Rutherford, S. C., Evens, A. M., … Friedberg, J. W. (2023). NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826. Hematological Oncology, 41(S2), 33–35. https://doi.org/10.1002/hon.3163_5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free